GSS vs PHX

ASX Healthcare sector comparison — updated 14 Jul 2026 — Healthcare sector

GSS

GENETICSIG FPO [GSS]

54MEDIUM

PHX

PHARMX FPO [PHX]

42LOW

Score Breakdown

GSS PHX
Technical
50
57
Catalyst
65
51
Sentiment
50
50
Fundamental
59
66
Momentum
31
55
Risk Gate
50
50

Key Metrics

GSS Metric PHX
$14.5MMarket Cap$79.1M
877KAvg Volume (20d)448K
N/AShort InterestN/A
$0.43052-Week High$0.200
$0.05752-Week Low$0.084
-1.6%Daily Change+0.0%
$0.063Reference Price$0.120
-22.8%ROE-5.9%
-56.5%Profit Margin-12.2%

Active Signals

GSS Signals

●RSI drifting toward oversold territory — worth watching
●Trading below both moving averages — the trend is working against this one
●Volume-price trend says buyers are quietly accumulating — price hasn't caught up yet
●Below the 200-day average — the long-term trend is still working against it
●Strong cash runway (12 quarters)
●Low P/S ratio (0.7x)
●EPS estimates revised downward (-10pts)
●Near 52-week low (2% of range)

PHX Signals

●Beating the Small Ords index — relative strength of 1.12, so it's outpacing the pack
●Below the 200-day average — the long-term trend is still working against it
●Cash positive / operating cashflow positive
●Moderate P/S ratio (10.3x)
●Small-cap ($20-100M)
●Capital raise activity (1 events)
●CANSLIM S: Tight float (41%)
●Negative profit margins (-12%)

Ask Scout AI to compare GSS and PHX in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener

Related Comparisons

GSS vs PKY →GSS vs RHY →HIQ vs ICR →HIQ vs IDX →HIQ vs LTP →
GSS Full Analysis → PHX Full Analysis → Healthcare Sector → All Comparisons →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).